Assignee
METABASIS THERAPEUTICS INC
US·51 granted patents·10 pending applications·2,162 citations·filing 1995–2019
Top patents by PatentIndex Score
61 records- 0198US6489476B1Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1999·Granted Dec 3, 2002·231 cites·165 claims
- 0298US6312662B1Prodrugs phosphorus-containing compoundsMETABASIS THERAPEUTICS INC·Filed 1999·Granted Nov 6, 2001·384 cites·183 claims
- 0397US6752981B1Prodrugs for liver specific drug deliveryMETABASIS THERAPEUTICS INC·Filed 2000·Granted Jun 22, 2004·105 cites·92 claims
- 0497US6399782B1Benzimidazole inhibitors of fructose 1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 2000·Granted Jun 4, 2002·136 cites·37 claims
- 0596US6110903ABenzimidazole inhibitors of fructose 1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1998·Granted Aug 29, 2000·132 cites·52 claims
- 0696US6054587AIndole and azaindole inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1998·Granted Apr 25, 2000·147 cites·47 claims
- 0795US6946115B2Prodrugs for phosphorus-containing compoundsMETABASIS THERAPEUTICS INC·Filed 2001·Granted Sep 20, 2005·51 cites·18 claims
- 0895US6294672B1Indole and azaindole inhibitors of Fructose-1,6-biphosphataseMETABASIS THERAPEUTICS INC·Filed 2000·Granted Sep 25, 2001·52 cites·22 claims
- 0995US6284748B1Purine inhibitors of fructose 1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1998·Granted Sep 4, 2001·137 cites·39 claims
- 1094US7514419B2Phosphorus-containing thyromimeticsMETABASIS THERAPEUTICS INC·Filed 2005·Granted Apr 7, 2009·25 cites·18 claims
- 1194US6965033B2Bisamidate phosphonate prodrugsMETABASIS THERAPEUTICS INC·Filed 2000·Granted Nov 15, 2005·57 cites·55 claims
- 1291US7351399B2Prodrugs for phosphorus-containing compoundsMETABASIS THERAPEUTICS INC·Filed 2005·Granted Apr 1, 2008·8 cites·9 claims
- 1390US7582758B2Lewis acid mediated synthesis of cyclic estersMETABASIS THERAPEUTICS INC·Filed 2005·Granted Sep 1, 2009·18 cites·39 claims
- 1490US7553826B2Cytarabine monophosphate prodrugsMETABASIS THERAPEUTICS INC·Filed 2006·Granted Jun 30, 2009·11 cites·29 claims
- 1589US7666855B22′-C-methyl nucleoside derivativesMETABASIS THERAPEUTICS INC·Filed 2006·Granted Feb 23, 2010·12 cites·37 claims
- 1689US5763597AOrally active adenosine kinase inhibitorsMETABASIS THERAPEUTICS INC·Filed 1996·Granted Jun 9, 1998·125 cites·28 claims
- 1789US5763596AC-4' modified adenosine kinase inhibitorsMETABASIS THERAPEUTICS INC·Filed 1996·Granted Jun 9, 1998·117 cites·32 claims
- 1888US7816345B2Phosphorus-containing prodrugsMETABASIS THERAPEUTICS INC·Filed 2007·Granted Oct 19, 2010·8 cites·55 claims
- 1988US6967193B1Purine inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 2003·Granted Nov 22, 2005·27 cites·6 claims
- 2088US6919322B2Phenyl Phosphonate Fructose-1,6-Bisphosphatase InhibitorsMETABASIS THERAPEUTICS INC·Filed 2001·Granted Jul 19, 2005·28 cites·56 claims
- 2188US6680379B1Organic anion transporter genes and proteinsMETABASIS THERAPEUTICS INC·Filed 2000·Granted Jan 20, 2004·14 cites·20 claims
- 2287US7829552B2Phosphorus-containing thyromimeticsMETABASIS THERAPEUTICS INC·Filed 2004·Granted Nov 9, 2010·24 cites·16 claims
- 2387US5795977AWater soluble adenosine kinase inhibitorsMETABASIS THERAPEUTICS INC·Filed 1996·Granted Aug 18, 1998·106 cites·21 claims
- 2486US9701626B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2015·Granted Jul 11, 2017·5 cites·10 claims
- 2586US9169201B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2014·Granted Oct 27, 2015·8 cites·13 claims
- 2685US10034891B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2016·Granted Jul 31, 2018·2 cites·4 claims
- 2785US7205404B1Phosphorus-containing prodrugsMETABASIS THERAPEUTICS INC·Filed 2000·Granted Apr 17, 2007·17 cites·61 claims
- 2885US7151092B2Cytarabine monophosphate prodrugsMETABASIS THERAPEUTICS INC·Filed 2003·Granted Dec 19, 2006·13 cites·11 claims
- 2984US10925885B2Thyromimetics for the treatment of fatty liver diseasesMETABASIS THERAPEUTICS INC·Filed 2018·Granted Feb 23, 2021·4 cites·25 claims
- 3083US7498320B2Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugsMETABASIS THERAPEUTICS INC·Filed 2006·Granted Mar 3, 2009·5 cites·64 claims
- 3182US9340566B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2015·Granted May 17, 2016·2 cites·10 claims
- 3282US7303739B2Prodrugs for liver specific drug deliveryMETABASIS THERAPEUTICS INC·Filed 2004·Granted Dec 4, 2007·14 cites·88 claims
- 3382US6756360B1Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetesMETABASIS THERAPEUTICS INC·Filed 1999·Granted Jun 29, 2004·48 cites·74 claims
- 3481US7381736B2Thiazole and thiadiazole inhibitors of tyrosine phosphatasesMETABASIS THERAPEUTICS INC·Filed 2005·Granted Jun 3, 2008·7 cites·19 claims
- 3580US10239829B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2017·Granted Mar 26, 2019·2 cites·20 claims
- 3680US7371739B2Aryl fructose-1,6-bisphosphatase inhibitorsMETABASIS THERAPEUTICS INC·Filed 2005·Granted May 13, 2008·4 cites·79 claims
- 3779US9783494B2Glucagon antagonistsMETABASIS THERAPEUTICS INC·Filed 2014·Granted Oct 10, 2017·3 cites·21 claims
- 3879US7312219B2Heteroaromatic inhibitors of fructose 1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 2003·Granted Dec 25, 2007·10 cites·145 claims
- 3979US7214668B2Phosphonic acid based prodrugs of PMEA and its analoguesMETABASIS THERAPEUTICS INC·Filed 2003·Granted May 8, 2007·16 cites·30 claims
- 4078US7193081B2Process for preparation of cyclic prodrugs of PMEA and PMPAMETABASIS THERAPEUTICS INC·Filed 2003·Granted Mar 20, 2007·13 cites·66 claims
- 4177US7285543B2Purine inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 2005·Granted Oct 23, 2007·2 cites·6 claims
- 4276US10709718B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2018·Granted Jul 14, 2020·1 cites·11 claims
- 4376US7148349B2Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugsMETABASIS THERAPEUTICS INC·Filed 2003·Granted Dec 12, 2006·7 cites·80 claims
- 4475US10221130B2Glucagon antagonistsMETABASIS THERAPEUTICS INC·Filed 2017·Granted Mar 5, 2019·1 cites·14 claims
- 4573US11352321B2Glucagon antagonistsMETABASIS THERAPEUTICS INC·Filed 2019·Granted Jun 7, 2022·0 cites·15 claims
- 4669US2008004226A1Combination of FBPase Inhibitors and Insulin Sensitizers for the Treatment of DiabetesMETABASIS THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 4768US10807946B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2019·Granted Oct 20, 2020·0 cites·10 claims
- 4862US2008015195A1Novel Heteroaromatic Inhibitors of Fructose-1,6-BisphosphataseMETABASIS THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 4961US2007249564A1Novel phosphorus-containing prodrugsMETABASIS THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 5061US2007232571A1Novel Heteroaromatic Inhibitors of Fructose-1,6-BisphosphataseMETABASIS THERAPEUTICS INC·Filed 2007·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →